Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys, Inc. (NASDAQ: AMED) is a healthcare at home company that reports on developments across home health, hospice and high acuity care services delivered in the home. The Amedisys news flow includes regular earnings announcements, corporate updates and clinical program disclosures that reflect its role in the home health care services industry.
Investors and observers following AMED news can expect detailed quarterly and annual financial results, including net service revenue, net income, adjusted EBITDA and other non-GAAP measures that Amedisys reconciles to GAAP in its releases. These earnings communications often discuss factors such as merger-related expenses, impairment charges and other items that affect reported and adjusted results.
Amedisys also issues news about its clinical initiatives and partnerships. For example, the company has announced the rollout of advanced molecular testing for infection diagnosis in collaboration with Patient Choice Laboratories, aimed at improving the speed and accuracy of identifying pathogens in urine, respiratory and wound infections in the home setting. Through its subsidiary Contessa Health, Amedisys has highlighted participation in models such as the Centers for Medicare & Medicaid Services’ GUIDE Model for dementia care, reflecting activity in alternative payment and care delivery models.
Other Amedisys news items cover recognition for patient and caregiver satisfaction, such as SHPBest™ awards for home health and hospice care centers, and updates related to its merger with UnitedHealth Group, including regulatory and legal milestones. Readers who monitor AMED news gain insight into the company’s financial performance, regulatory environment, care quality indicators and the evolution of its home-based service offerings.
Amedisys, Inc. (NASDAQ: AMED), a prominent provider of home health and hospice services, announced its participation in the Raymond James & Associates' 43rd Annual Institutional Investors Conference. Chris Gerard, President and COO, along with Scott Ginn, CFO, will present on March 8 at 11:35 a.m. EST. Interested individuals can access the live webcast through Amedisys' investor relations website. The company, founded in 1982 and based in Baton Rouge, serves over 418,000 patients annually with a workforce of approximately 21,000 employees across 529 care centers in 38 states.
Amedisys, Inc. (NASDAQ: AMED) reported Q4 2021 net service revenue of $559.3 million, up $8.6 million from Q4 2020. However, net income decreased to $34.0 million, or $1.04 per diluted share, down from $45.2 million, or $1.36, in the previous year. For the full year, revenue climbed to $2,214.1 million, with net income rising to $209.1 million. The company anticipates 2022 adjusted net service revenue between $2.330 billion and $2.365 billion, amid ongoing COVID-19 impacts. The CEO expressed optimism about future growth opportunities as the company adapts to evolving healthcare needs.
Virginia Mason Franciscan Health has partnered with Contessa, an Amedisys company (NASDAQ: AMED), to launch Home Recovery Care, enabling patients to receive hospital-level care at home. This initiative aims to enhance access to high-acuity care, increase inpatient capacity, and lower overall healthcare costs. The program, starting at St. Joseph Medical Center in Tacoma, will initially serve Medicare fee-for-service patients and includes remote monitoring, nursing visits, and telehealth consultations. Historically, this care model has reduced readmission rates by 44% and hospital stay lengths by 35%.
Amedisys, Inc. (NASDAQ: AMED) announced the acquisition of home health assets from AssistedCare Home Health, enhancing its services in North Carolina. The deal, set to close on or around April 1, 2022, will allow Amedisys to serve over 1.5 million Medicare enrollees in the state. AssistedCare's home health operations will transition to Amedisys, promoting a strategy focused on aging in place. Post-acquisition, Amedisys will encompass 350 care centers across 34 states, with approximately 74,000 daily patients, significantly expanding its community reach.
Amedisys, Inc. (AMED) has signed a definitive agreement to acquire Evolution Health, LLC, enhancing its home health services. The acquisition, expected to close in the first half of 2022, will allow Amedisys to serve over 1.9 million Medicare enrollees in Texas and over 800,000 in Ohio, increasing its network to 346 care centers across 34 states. This move aims to strengthen Amedisys' position as a quality home healthcare provider, expanding patient access and aligning with existing hospice services.
Amedisys, Inc. (NASDAQ: AMED) will report its fourth quarter and full year results for 2021 on February 23, 2022, after market close. An investor conference call is scheduled for February 24, 2022, at 11:00 a.m. ET. Participants can join by dialing (877) 524-8416 or (412) 902-1028. A replay will be available until March 24, 2022. A live webcast will also be accessible on the Company's Investor Relations website. Amedisys focuses on delivering personalized home health, hospice, personal care, and higher acuity care services nationwide.
Summary not available.
Amedisys (NASDAQ: AMED) announced the retirement of CEO Paul Kusserow effective April 15, 2022, after seven years in the role. He will remain as Chairman of the Board. Chris Gerard, currently President and COO, will succeed him as CEO. Under Kusserow’s leadership, Amedisys improved its Home Health Quality of Patient Care Star score from 3.5 to 4.33 and expanded its business significantly, increasing market cap from $900 million to over $5.3 billion. The leadership transition is expected to be seamless, with Gerard highlighting growth opportunities ahead.
Amedisys, a leading provider of home health and hospice services, will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12 at 3:45 p.m. EST. The presentation will feature key executives including Paul B. Kusserow, Chris Gerard, and Scott Ginn. Interested parties can access the live webcast through the company's website. Amedisys focuses on delivering personalized patient care across various service lines, catering to over 418,000 patients annually. The company has a significant presence, with approximately 21,000 employees and 529 care centers nationwide.
Amedisys, a prominent provider of in-home healthcare, announced key presentations at the Bank of America Securities 2021 Virtual Healthcare Conference. Scheduled for December 6 at 9:00 a.m. Eastern, the presentation will feature Paul B. Kusserow, Chris Gerard, and Scott Ginn. Amedisys specializes in home health, hospice, and personal care services, partnering with over 2,900 hospitals and 78,000 physicians. The company, headquartered in Baton Rouge, serves over 418,000 patients annually, employing around 21,000 staff across 529 care centers in 38 states.